These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19724778)

  • 1. Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.
    Wesierska-Gadek J; Borza A; Komina O; Maurer M
    Acta Biochim Pol; 2009; 56(3):495-501. PubMed ID: 19724778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells.
    Maurer M; Komina O; Wesierska-Gadek J
    Ann N Y Acad Sci; 2009 Aug; 1171():250-6. PubMed ID: 19723062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment.
    Wesierska-Gadek J; Borza A; Walzi E; Krystof V; Maurer M; Komina O; Wandl S
    J Cell Biochem; 2009 Apr; 106(5):937-55. PubMed ID: 19180585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
    Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
    Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
    Wesierska-Gadek J; Gueorguieva M; Horky M
    Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells.
    Wesierska-Gadek J; Schmitz ML; Ranftler C
    J Cell Biochem; 2007 Mar; 100(4):865-74. PubMed ID: 17203463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.
    Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
    J Cell Biochem; 2011 Mar; 112(3):761-72. PubMed ID: 21328450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells.
    Wesierska-Gadek J; Hajek SB; Sarg B; Wandl S; Walzi E; Lindner H
    Biochem Pharmacol; 2008 Dec; 76(11):1503-14. PubMed ID: 18761330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells.
    Wesierska-Gadek J; Wandl S; Kramer MP; Pickem C; Krystof V; Hajek SB
    J Cell Biochem; 2008 Dec; 105(5):1161-71. PubMed ID: 18846503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER.
    Zulehner N; Maurer M; Wesierska-Gadek J
    J Exp Ther Oncol; 2011; 9(1):17-25. PubMed ID: 21275262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.
    Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
    J Cell Biochem; 2011 Apr; 112(4):1103-17. PubMed ID: 21308739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors.
    Węsierska-Gądek J; Hackl S; Zulehner N; Maurer M; Komina O
    J Cell Biochem; 2011 Jan; 112(1):273-88. PubMed ID: 21080333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenol red reduces ROSC mediated cell cycle arrest and apoptosis in human MCF-7 cells.
    Wesierska-Gadek J; Schreiner T; Gueorguieva M; Ranftler C
    J Cell Biochem; 2006 Aug; 98(6):1367-79. PubMed ID: 16741967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest.
    Wesierska-Gadek J; Maurer M; Schmid G
    J Cell Biochem; 2007 Oct; 102(3):736-47. PubMed ID: 17415788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.
    Komina O; Wesierska-Gadek J
    Biochem Pharmacol; 2008 Dec; 76(11):1554-62. PubMed ID: 18761329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose.
    Kramer MP; Wesierska-Gadek J
    Ann N Y Acad Sci; 2009 Aug; 1171():257-63. PubMed ID: 19723063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
    Wesierska-Gadek J; Kramer MP; Maurer M
    Food Chem Toxicol; 2008 Apr; 46(4):1327-33. PubMed ID: 17933449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine.
    Videla-Richardson GA; Furmento VA; Garcia CP; Morris-Hanon O; Sevlever GE; Romorini L; Scassa ME
    BMC Mol Cell Biol; 2019 Aug; 20(1):40. PubMed ID: 31462218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine.
    Paprskárová M; Krystof V; Jorda R; Dzubák P; Hajdúch M; Wesierska-Gadek J; Strnad M
    J Cell Biochem; 2009 Jun; 107(3):428-37. PubMed ID: 19308936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of p53 degradation in human MCF-7 cells by proteasome inhibitors does not mimic the action of roscovitine.
    Ranftler C; Gueorguieva M; Wesierska-Gadek J
    Ann N Y Acad Sci; 2006 Dec; 1090():234-44. PubMed ID: 17384267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.